Global Mobile Apps for DNA Sequencing Market report published by Accurize Market Research forecast that the global market is expected to reach $255 billion by 2025; growing at a CAGR of 53.9% from 2017 to 2025. By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.

Request Sample: https://www.accurizemarketresearch.com/report/global-mobile-apps-for-dna-sequencing-market/sample-request

An upsurge in technological advancements in DNA sequencing, progression in collaborations & partnerships, and rise in genome mapping programs globally to drive the global market

An upsurge in technological advancements in DNA sequencing, progression in collaborations & partnerships, and rise in genome mapping programs globally fuels the growth of the global Mobile Apps for DNA Sequencing market. Moreover, a rise in investment in R&D and growth in lifestyle might also provide growth opportunities.

Market Segmentation

The global Mobile Apps for DNA Sequencing market is split into technology type, end-use, and geography. Technology type is segmented into sequencers, snapshot DNA phenol typing, nimblegen sequencing capture microarrays and services, master pure complete DNA/RNA purification kit -- Illumina, base space -- Illumina, tablets, 2g, 3g and 4g android "smart" phones, mobile apps, computational biology/rare diseases -- devices, NIH (U.S.) grants for computational biology/bioinformatics, general genomic device information, and phenotyping systems/platforms. End users further divided into genealogy, computational biology/rare diseases, invite IBM container service and others.

Request Customization: https://www.accurizemarketresearch.com/report/global-mobile-apps-for-dna-sequencing-market/ask-for-customization

North America, Europe, Asia-Pacific and Rest of the world (RoW) are the geographical segments of the market.

Top players in the market

Major companies operating in the market include 23andme, Ancestry, Exploragen, Familysearch, Helix, Hoffmann-La, Roche Ag, Illumina, Myheritage, Oxford Nanopore, and Pacific Biosciences, among others.